Vifor Pharma AG (VIFN:SW) (GNHAY) PT Lowered to CHF129 at UBS

October 21, 2020 3:43 PM EDT
Get Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 8 | New: 46
Trade Now! 
Join SI Premium – FREE
UBS analyst Laura Sutcliffe lowered the price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF129.00 (from CHF142.00) while maintaining a Neutral rating.

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Intl Ratings